It's True: Medical Cannabis Provides Dramatic Relief for Sufferers of Chronic Ailments

Treatment can improve appetite, ease chronic pain, and more, say TAU researchers

Moshe Roth
Moshe Roth, a Hadarim resident and participant in the TAU cannabis study.

Though controversial, medical cannabis has been gaining ground as a valid therapy, offering relief to suffers of diseases such as cancer, Post-Traumatic Stress Disorder, ALS and more. The substance is known to soothe severe pain, increase the appetite, and ease insomnia where other common medications fail.

In 2009, Zach Klein, a graduate of Tel Aviv University's Department of Film and Television Studies, directed the documentary Prescribed Grass. Through the process, he developed an interest in the scientific research behind medical marijuana, and now, as a specialist in policy-making surrounding medical cannabis and an MA student at TAU's Porter School of Environmental Studies, he is conducting his own research into the benefits of medical cannabis.

Using marijuana from a farm called Tikkun Olam — a reference to the Jewish concept of healing the world — Klein and his fellow researchers tested the impact of the treatment on 19 residents of the Hadarim nursing home in Israel. The results, Klein says, have been outstanding. Not only did participants experience dramatic physical results, including healthy weight gain and the reduction of pain and tremors, but Hadarim staff saw an immediate improvement in the participants' moods and communication skills. The use of chronic medications was also significantly reduced, he reports.

Klein's research team includes Dr. Dror Avisar of TAU's Hydrochemistry Laboratory at the Department of Geography and Human Environment; Prof. Naama Friedmann and Rakefet Keider of TAU's Jaime and Joan Constantiner School of Education; Dr. Yehuda Baruch of TAU's Sackler Faculty of Medicine and director of the Abarbanel Mental Health Center; and Dr. Moshe Geitzen and Inbal Sikorin of Hadarim.

Cutting down on chronic medications

Israel is a world leader in medical cannabis research, Klein says. The active ingredient in marijuana, THC, was first discovered there by Profs. Raphael Mechoulam and Yechiel Gaoni. Prof. Mechoulam is also credited for having defined the endocannabinoid system, which mimics the effects of cannabis and plays a role in appetite, pain sensation, mood and memory.

In the Hadarim nursing home, 19 patients between the ages of 69 and 101 were treated with medical cannabis in the form of powder, oil, vapor, or smoke three times daily over the course of a year for conditions such as pain, lack of appetite, and muscle spasms and tremors. Researchers and nursing home staff monitored participants for signs of improvement, as well as improvement in overall life quality, such as mood and ease in completing daily living activities.

During the study, 17 patients achieved a healthy weight, gaining or losing pounds as needed. Muscle spasms, stiffness, tremors and pain reduced significantly. Almost all patients reported an increase in sleeping hours and a decrease in nightmares and PTSD-related flashbacks.

There was a notable decline in the amount of prescribed medications taken by patients, such as antipsychotics, Parkinson's treatment, mood stabilizers, and pain relievers, Klein found, noting that these drugs have severe side effects. By the end of the study, 72 percent of participants were able to reduce their drug intake by an average of 1.7 medications a day.

Connecting cannabis and swallowing

This year, Klein is beginning a new study at Israel's Reuth Medical Center with Drs. Jean-Jacques Vatine and Aviah Gvion, in which he hopes to establish a connection between medical cannabis and improved swallowing. One of the biggest concerns with chronically ill patients is food intake, says Klein. Dysphagia, or difficulty in swallowing, can lead to a decline in nutrition and even death. He believes that cannabis, which has been found to stimulate regions of the brain associated with swallowing reflexes, will have a positive impact.

Overall, Klein believes that the healing powers of cannabis are close to miraculous, and has long supported an overhaul in governmental policy surrounding the drug. Since his film was released in 2009, the number of permits for medical cannabis in Israel has increased from 400 to 11,000. His research is about improving the quality of life, he concludes, especially for those who have no other hope.


For more medicine and health news from Tel Aviv University, click here

Keep up with the latest AFTAU news on Twitter: http://www.twitter.com/AFTAUnews

 

 

All active news articles
 

Quick links

Other recent news

  • Reversing Paralysis with a Restorative Gel
  • Positive Social Support at Work Shown to Reduce Risk of Diabetes
  • Business Education: The Path to Peace and Prosperity?
  • New York University to Establish Research Institute at TAU
  • Israel Prefers to Remain on Sidelines in Syrian Conflict, Former Israeli Ambassador to US Says
  • Will the Start Up Nation Become the Blast Off Nation?
  • From Tel Aviv to Ohio for a World-Class Education in Pediatrics
  • Sniffing Out Schizophrenia
  • TAU Researcher Honored for Innovative Work on Gauge and Gravity Theories
  • Looking for Life by the Light of Dying Stars
  • Henry Kissinger Is Featured Speaker at TAU's Hartog School Reception in New York
  • Using Black Holes to Measure the Universe's Rate of Expansion
  • Bursts of Brain Activity May Protect Against Alzheimer's Disease
  • "Legitimized Neo-Nazism" on the Rise Across Europe
  • Multidisciplinary Research on Physics of "Living Systems" Earns Prestigious Prize
  • Leading Theatre Director and TAU Professor Emeritus Awarded Israel Prize
  • Sustained Stress Heightens Risk of Miscarriage
  • President Obama Puts Much-Needed Money Where the Brain Is
  • New Relief for Gynecological Disorders
  • It's True! Feeling Powerful Leads to Happiness
  •